Study of the efficacy of naltrexone on positive and negative symptoms in schizophrenic patients
Phase 3
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT201110093010N4
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
all schizophrenic patients hospitalized in Farabi Hospital. Exclusion criteria: 1) Any patients who refuse to participate in the study. 2) Any sensitivity to naltrexone.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive and negative symptoms. Timepoint: Before the intervention and after 12 weeks. Method of measurement: PaNSS (Anderson test) scores.
- Secondary Outcome Measures
Name Time Method